Cyproterone acetate
- Generic Name
- Cyproterone acetate
- Brand Names
- Androcur, Cléo -35, Cyestra-35, Diane
- Drug Type
- Small Molecule
- Chemical Formula
- C24H29ClO4
- CAS Number
- 427-51-0
- Unique Ingredient Identifier
- 4KM2BN5JHF
- Background
An anti-androgen that, in the form of its acetate (cyproterone acetate), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.
- Indication
For the palliative treatment of patients with advanced prostatic carcinoma.
- Associated Conditions
- Menstrual Irregularities, Osteoporosis, Paraphilia, Postmenopausal Osteoporosis, Primary Amenorrhoea, Secondary Amenorrhea, Severe Acne, Advanced carcinoma of the prostate, Metastatic Carcinoma of the Prostate
- Associated Therapies
- Hormone Replacement Therapy
The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate
- Conditions
- Interventions
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2021-07-21
- Lead Sponsor
- Benha University
- Target Recruit Count
- 60
- Registration Number
- NCT04848181
- Locations
- 🇪🇬
Benha University, Banhā, Qalyubia, Egypt
Effects of Sex Steroids on the Serotonin System
- Conditions
- Interventions
- First Posted Date
- 2016-03-22
- Last Posted Date
- 2018-10-15
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 92
- Registration Number
- NCT02715232
- Locations
- 🇦🇹
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Phlebotomy and Polycystic Ovary Syndrome
- Conditions
- Interventions
- First Posted Date
- 2015-06-02
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Manuel Luque Ramírez
- Target Recruit Count
- 37
- Registration Number
- NCT02460445
- Locations
- 🇪🇸
Diabetes, Obesity and Human Reproduction Research Group, Department of Endocrinology and Nutrition, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain
Sex Steroids and the Serotonin Transporter
- Conditions
- Interventions
- First Posted Date
- 2010-02-09
- Last Posted Date
- 2014-01-03
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 32
- Registration Number
- NCT01065220
- Locations
- 🇦🇹
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma
- Conditions
- Interventions
- First Posted Date
- 2009-11-11
- Last Posted Date
- 2015-07-30
- Lead Sponsor
- Takeda
- Target Recruit Count
- 311
- Registration Number
- NCT01011751
- Locations
- 🇫🇷
Professor Jacques IRANI, Poitiers, France
Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer
- Conditions
Comparison of Two Pharmacological Treatments of Pedophilia
- First Posted Date
- 2008-01-28
- Last Posted Date
- 2009-07-13
- Target Recruit Count
- 48
- Registration Number
- NCT00601276
- Locations
- 🇫🇷
Federation d'Endocrinologie, Hopital NeuroCardiologique, Bron, France
🇫🇷Centre MédicoPsychologique CMPG21, EPS Perray Vaucluse, Paris, France
🇫🇷Service de Psychiatrie, Hopital Foch, Suresnes, France
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
- Conditions
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2013-08-26
- Lead Sponsor
- St. Bartholomew's Hospital
- Target Recruit Count
- 900
- Registration Number
- NCT00363285
- Locations
- 🇬🇧
Scarborough General Hospital, Scarborough, England, United Kingdom
🇬🇧Saint Bartholomew's Hospital, London, England, United Kingdom
Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer
- Conditions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Barr Laboratories
- Registration Number
- NCT00005623
- Locations
- 🇺🇸
Barr Laboratories, Incorporated, Pomona, New York, United States
Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2021-06-23
- Lead Sponsor
- NCIC Clinical Trials Group
- Target Recruit Count
- 1386
- Registration Number
- NCT00003653
- Locations
- 🇨🇦
BCCA - Cancer Centre for the Southern Interior, Kelowna, British Columbia, Canada
🇨🇦BCCA - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada
🇨🇦Clinical Research Unit at Vancouver Coastal, Vancouver, British Columbia, Canada
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.